Leger Damien, Tonetti Lorenzo, Gauriau Caroline, Faraut Brice, Elbaz Maxime, Sauvet Fabien, Natale Vincenzo
Université Paris Descartes, APHP, Hôtel Dieu, Centre du Sommeil et de la Vigilance, Centre de référence hypersomnies rares et EA 7330 VIFASOM, 1 place du Parvis Notre-Dame, 75004 Paris, France.
Department of Psychology, University of Bologna, Viale Berti Pichat 5, 40127 Bologna, Italy.
Clin Neurophysiol Pract. 2019 May 17;4:114-118. doi: 10.1016/j.cnp.2019.04.004. eCollection 2019.
The aim of the present study was to assess the optimal length of actigraphic recordings in patients with narcolepsy type 1.
A secondary analysis was carried out with the previously collected data in eleven patients with narcolepsy type 1. Ten of the 11 patients were medicated at the time of actigraphic recording. Each patient originally wore an Actiwatch AW64 actigraph for at least 28 consecutive days. Overall, the patients were analyzed for 308 nights.
No significant differences were observed between the mean values of the 7-day and 14-day analyzed sets for the parameters sleep efficiency, fragmentation index, sleep onset latency, wake after sleep onset, and total sleep time.
Our data suggest that 7 days of actigraphic recording could be sufficient for these patients.
Our results for the optimal length of actigraphic recording could be useful for both physicians and patients.
本研究旨在评估1型发作性睡病患者活动记录仪记录的最佳时长。
对之前收集的11例1型发作性睡病患者的数据进行二次分析。11例患者中有10例在进行活动记录仪记录时正在接受药物治疗。每位患者最初佩戴Actiwatch AW64活动记录仪至少连续28天。总体而言，对患者进行了308个夜晚的分析。
在睡眠效率、片段化指数、入睡潜伏期、睡眠中觉醒和总睡眠时间等参数的7天和14天分析组平均值之间未观察到显著差异。
我们的数据表明，7天的活动记录仪记录对这些患者可能就足够了。
我们关于活动记录仪记录最佳时长的结果可能对医生和患者都有用。
